Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment

Volumn 70, Issue , 2016, Pages 73-80

  Lindblad, Robert ^a   Hu, Lian ^a   Oden, Neal ^a   Wakim, Paul ^b   Rosa, Carmen ^c   VanVeldhuisen, Paul ^a  

^a EMMES CORPORATION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Clinical trial; Pooled analysis; Standardized mortality rate; Standardized mortality ratio; Substance use disorder

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOLISM; ARTICLE; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX RATIO; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; UNITED STATES; META ANALYSIS; MORTALITY; STANDARDS; STATISTICS AND NUMERICAL DATA;

HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 84984692536     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2016.08.010     Document Type: Article

References (43)

1. Arendt, M, Munk-Jorgensen, P, Sher, L, Jensen, SO, Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment. Drug and Alcohol Dependence 114 (2011), 134–139, 10.1016/j.drugalcdep.2010.09.013 (S0376–8716(10)00327–3 [pii]).
2. Breslow, NE, Day, NE, Statistical methods in cancer research. Volume II—The design and analysis of cohort studies. IARC Scientific Publications, 1987, 1–406.
3. Calsyn, DA, Hatch-Maillette, M, Tross, S, Doyle, SR, Crits-Christoph, P, Song, YS,. Berns, SB, Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. Journal of Substance Abuse Treatment 37 (2009), 138–150, 10.1016/j.jsat.2008.11.008S0740-5472(08)00221-3 (pii).
4. Campbell, BK, Tillotson, CJ, Choi, D, Bryant, K, DiCenzo, J, Provost, SE,. McCarty, D, Predicting outpatient treatment entry following detoxification for injection drug use: The impact of patient and program factors. Journal of Substance Abuse Treatment 38:Suppl 1 (2010), S87–S96, 10.1016/j.jsat.2009.12.012S0740-5472(10)00024-3 (pii).
5. Carroll, KM, Ball, SA, Nich, C, Martino, S, Frankforter, TL, Farentinos, C,. Woody, GE, Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 81 (2006), 301–312, 10.1016/j.drugalcdep.2005.08.002 (S0376-8716(05)00248-6 [pii]).
6. Chang, IM, Gelman, R, Pagano, M, Corrected group prognostic curves and summary statistics. Journal of Chronic Diseases 35 (1982), 669–674.
7. Darke, S, Mills, KL, Ross, J, Teesson, M, Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug and Alcohol Dependence 115 (2011), 190–195, 10.1016/j.drugalcdep.2010.10.021 (S0376–8716(10)00381–9 [pii]).
8. Degenhardt, L, Bucello, C, Mathers, B, Briegleb, C, Ali, H, Hickman, M, McLaren, J, Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction 106 (2011), 32–51, 10.1111/j.1360-0443.2010.03140.x.
9. Degenhardt, L, Singleton, J, Calabria, B, McLaren, J, Kerr, T, Mehta, S,. Hall, WD, Mortality among cocaine users: A systematic review of cohort studies. Drug and Alcohol Dependence 113 (2011), 88–95, 10.1016/j.drugalcdep.2010.07.026 (S0376-8716(10)00289-9 [pii]).
10. Donovan, DM, Daley, DC, Brigham, GS, Hodgkins, CC, Perl, HI, Garrett, SB,. Zammarelli, L, Stimulant abuser groups to engage in 12-step: A multisite trial in the National Institute on Drug Abuse Clinical Trials Network. Journal of Substance Abuse Treatment 44 (2013), 103–114, 10.1016/j.jsat.2012.04.004S0740-5472(12)00081-5 (pii).
11. Fay, MP, Feuer, EJ, Confidence intervals for directly standardized rates: A method based on the gamma distribution. Statistics in Medicine 16 (1997), 791–801.
12. Fenoglio, P, Parel, V, Kopp, P, The social cost of alcohol, tobacco and illicit drugs in France, 1997. European Addiction Research 9 (2003), 18–28 (doi: 6773067730 [pii).
13. Ghali, WA, Quan, H, Brant, R, van Melle, G, Norris, CM, Faris, PD,. Knudtson, ML, Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA : the journal of the American Medical Association 286 (2001), 1494–1497 (doi: jsc10095 [pii).
14. Gossop, M, Stewart, D, Treacy, S, Marsden, J, A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 97 (2002), 39–47 (doi: 79 [pii).
15. Hall, WD, Degenhardt, LJ, Lynskey, MT, Opioid overdose mortality in Australia, 1964–1997: birth-cohort trends. The Medical Journal of Australia 171 (1999), 34–37.
16. Hien, DA, Jiang, H, Campbell, AN, Hu, MC, Miele, GM, Cohen, LR,. Nunes, EV, Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. The American Journal of Psychiatry 167 (2010), 95–101, 10.1176/appi.ajp.2009.09091261appi.ajp.2009.09091261 (pii).
17. Hien, DA, Wells, EA, Jiang, H, Suarez-Morales, L, Campbell, AN, Cohen, LR,. Nunes, EV, Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical Psychology 77 (2009), 607–619, 10.1037/a00162272009-11168-002 (pii).
18. Horigian, VE, Robbins, MS, Dominguez, R, Ucha, J, Rosa, CL, Principles for defining adverse events in behavioral intervention research: lessons from a family-focused adolescent drug abuse trial. Clinical Trials 7 (2010), 58–68, 10.1177/17407745093565757/1/58 (pii).
19. Joe, GW, Lehman, W, Simpson, DD, Addict death rates during a four-year posttreatment follow-up. American Journal of Public Health 72 (1982), 703–709.
20. Korthuis, PT, Feaster, DJ, Gomez, ZL, Das, M, Tross, S, Wiest, K,. Metsch, LR, Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness. Addictive Behaviors 37 (2012), 552–555, 10.1016/j.addbeh.2011.12.001S0306-4603(11)00402-3 (pii).
21. Kropp, F, Somoza, E, Lilleskov, M, Moccasin, MG, Moore, M, Lewis, D,. Winhusen, T, Characteristics of Northern Plains American Indians seeking substance abuse treatment in an urban, non-tribal clinic: a descriptive study. Community Mental Health Journal 49 (2013), 714–721, 10.1007/s10597-012-9537-7.
22. Last, J.M., (eds.) A dictionary of epidemiology, 1983, Oxford University Press, New York.
23. Liddell, FD, Simple exact analysis of the standardised mortality ratio. Journal of Epidemiology and Community Health 38 (1984), 85–88.
24. Masson, CL, Shopshire, MS, Sen, S, Hoffman, KA, Hengl, NS, Bartolome, J,. Iguchi, MY, Possible barriers to enrollment in substance abuse treatment among a diverse sample of Asian Americans and Pacific Islanders: Opinions of treatment clients. Journal of Substance Abuse Treatment 44 (2013), 309–315, 10.1016/j.jsat.2012.08.005S0740-5472(12)00140-7 (pii).
25. McCarty, D, Fuller, B, Kaskutas, LA, Wendt, WW, Nunes, EV, Miller, M,. Edmundson, E, Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence 92 (2008), 200–207, 10.1016/j.drugalcdep.2007.08.004 (S0376–8716(07)00295–5 [pii]).
26. McLellan, AT, Luborsky, L, Woody, GE, O'Brien, CP, An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 168 (1980), 26–33.
27. Meade, CS, Weiss, RD, Fitzmaurice, GM, Poole, SA, Subramaniam, GA, Patkar, AA,. Woody, GE, HIV risk behavior in treatment-seeking opioid-dependent youth: Results from a NIDA clinical trials network multisite study. Journal of Acquired Immune Deficiency Syndromes 55 (2010), 65–72, 10.1097/QAI.0b013e3181d916db.
28. ONDCP, National Drug Control Strategy 2012. Policy & Research, 2012 (Retrieved January 18, 2012, from http://www.whitehouse.gov/sites/default/files/ondcp/2012_ndcs.pdf).
29. Paulozzi, LJ, Weisler, RH, Patkar, AA, A national epidemic of unintentional prescription opioid overdose deaths: How physicians can help control it. Journal of Clinical Psychiatry 72 (2011), 589–592.
30. Porta, M., (eds.) A dictionary of Epidemiology, 6th ed., 2014, Oxford University Press, New York City, U.S.A.
31. Rehm, J, Frick, U, Hartwig, C, Gutzwiller, F, Gschwend, P, Uchtenhagen, A, Mortality in heroin-assisted treatment in Switzerland 1994–2000. Drug and Alcohol Dependence 79 (2005), 137–143, 10.1016/j.drugalcdep.2005.01.005 (S0376–8716(05)00031–1 [pii]).
32. Sahai, H, Khurshid, A, Confidence intervals for the mean of a Poisson distribution: A review. Biometrical Journal 35 (1993), 857–867.
33. Simmonds, MC, Higgins, JP, Stewart, LA, Tierney, JF, Clarke, MJ, Thompson, SG, Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2 (2005), 209–217.
34. Svikis, DS, Keyser-Marcus, L, Stitzer, M, Rieckmann, T, Safford, L, Loeb, P,. Zweben, J, Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug and Alcohol Dependence 120 (2012), 55–64, 10.1016/j.drugalcdep.2011.06.024S0376-8716(11)00302-4 (pii).
35. Tai, B, Straus, MM, Liu, D, Sparenborg, S, Jackson, R, McCarty, D, The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment 38:Suppl 1 (2010), S4–13, 10.1016/j.jsat.2010.01.011S0740-5472(10)00025-5 (pii).
36. Tyndall, MW, Craib, KJ, Currie, S, Li, K, O'Shaughnessy, MV, Schechter, MT, Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes 28 (2001), 351–357.
37. United Nations Office on Drugs and Crime, World drug report 2012. 2012, United Nations Publications, New York, NY, USA, 7–57.
38. Watterson, O, Simpson, DD, Sells, SB, Death rates and causes of death among opioid addicts in community drug treatment programs during 1970–1973. American Journal of Drug and Alcohol Abuse 2 (1975), 99–111.
39. Weiss, RD, Potter, JS, Fiellin, DA, Byrne, M, Connery, HS, Dickinson, W,. Ling, W, Adjunctive counseling during brief and extended buprenorphine–naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 68 (2011), 1238–1246, 10.1001/archgenpsychiatry.2011.121archgenpsychiatry.2011.121 (pii).
40. Wells, EA, Saxon, AJ, Calsyn, DA, Jackson, TR, Donovan, DM, Study results from the Clinical Trials Network's first 10 years: Where do they lead?. Journal of Substance Abuse Treatment 38:Suppl 1 (2010), S14–S30, 10.1016/j.jsat.2009.12.009S0740-5472(10)00019-X (pii).
41. Winhusen, T, Winstanley, EL, Somoza, E, Brigham, G, The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Drug and Alcohol Dependence 120 (2012), 225–228, 10.1016/j.drugalcdep.2011.06.014S0376-8716(11)00277-8 (pii).
42. Woody, GE, Poole, SA, Subramaniam, G, Dugosh, K, Bogenschutz, M, Abbott, P,. Fudala, P, Extended vs short-term buprenorphine–naloxone for treatment of opioid-addicted youth: A randomized trial. JAMA : the journal of the American Medical Association 300 (2008), 2003–2011, 10.1001/jama.2008.574300/17/2003 (pii).
43. Zhang, JB, Yu, XF, A SAS® program for estimating incidence density for cohort studies with multiple follow-ups. PH008. 2008 (Retrieved August, 2012, from http://www.nesug.org/proceedings/nesug03/ph/ph008.pdf).